Article may be outdated

This article is 9 days old. Some details may have changed since publication.

Medical Xpress·3 min read·hard

Liver-directed gene therapy shows preclinical efficacy for severe inherited metabolic disorder

T
Telethon Foundation
Liver-directed gene therapy shows preclinical efficacy for severe inherited metabolic disorder
AI Summary

Researchers have published preclinical data showing that a liver-directed gene therapy can effectively treat methylmalonic acidemia (MMA) in mice. The study demonstrates sustained improvements in disease markers, offering hope for a future treatment for this rare metabolic disorder.

edited by Gaby Clark , reviewed by Andrew Zinin

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
sciencehealth

Get the full story

Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.

Create free account

Already have an account? Sign in

Liver-directed gene therapy shows preclinical efficacy for severe inherited metabolic disorder — Headlinne — headlinne